If you have treatment-resistant epilepsy, you may benefit from recent advances in surgical procedures.
13 Common Epilepsy Myths, Debunked
Some myths about epilepsy are centuries old, but they still persist. Imad Najm, MD, dispels 13 of the most common ones.
A Pouty Frown Can Offer Vital Clue for Your Epilepsy Diagnosis
An involuntary frown (ictal pouting) is a subtle but specific sign of a frontal lobe seizure. Identifying it can speed diagnosis and treatment for your epilepsy.
First Marijuana-Based Drug Approved for Treatment of Severe Forms of Epilepsy
An epilepsy expert explains the science behind a new CBD treatment for seizures associated with two rare forms of severe childhood-onset epilepsy: Lennox-Gastaut syndrome or Dravet syndrome.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Surprising Fact About Epilepsy: It’s More Common Than You May Think
Striking new results provide important information for public health planning.
How a New Tool Can Help Your Decision About Epilepsy Surgery
Fortunately, the risks for epilepsy surgery are low, and in fact, research has shown that it’s safer to proceed with surgery than to continue for a lifetime with uncontrolled epilepsy.
Why It’s Best to Accept an Epilepsy Diagnosis
When patients and families accept the diagnosis, they may embrace it as the “new normal” and focus on taking control.
Why Some Seizures Are Not Caused By Epilepsy
It can often be difficult for friends and family to tell the difference between epileptic and non-epileptic seizures, since the outward signs are similar.
Deja Vu: What It Is, When It May Be Cause for Concern
Ever have the sensation that you’ve been somewhere or talked to someone before, when you know you haven’t? That’s deja vu. Discover some insights into this mental phenomenon and learn when it may signal a problem.
5 Ways You Can Manage Rising Prescription Drug Costs
For patients without low-cost alternatives, the financial burden of drug therapy may be serious.
